RT Journal Article
SR Electronic
T1 Considerations for treatment duration in responders to immune checkpoint inhibitors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e001901
DO 10.1136/jitc-2020-001901
VO 9
IS 3
A1 Marron, Thomas U
A1 Ryan, Aideen E
A1 Reddy, Sangeetha M
A1 Kaczanowska, Sabina
A1 Younis, Rania H
A1 Thakkar, Dipti
A1 Zhang, Jiajia
A1 Bartkowiak, Todd
A1 Howard, Rachel
A1 Anderson, Kristin G
A1 Olson, Daniel
A1 Naqash, Abdul Rafeh
A1 Patel, Ravi B
A1 Sachdev, Esha
A1 Rodriguez-Ruiz, Maria E
A1 Sheffer, Michal
A1 Church, Sarah
A1 Fuhrman, Christopher
A1 Overacre-Delgoffe, Abigail
A1 Nguyen, Rosa
A1 Florou, Vaia
A1 Thaxton, Jessica E
A1 Aggen, David H
A1 Guerriero, Jennifer L
YR 2021
UL http://jitc.bmj.com/content/9/3/e001901.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.